Published in Minerva Urol Nefrol on June 01, 2002
A review of penile metastasis. Oncol Rev (2012) 0.78
Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nat Genet (1994) 2.55
Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate (1996) 1.85
Neuroendocrine differentiation in human prostate tissue: is it detectable and treatable? BJU Int (2003) 1.50
Interstitial deletion 13q syndromes: a report on two unrelated patients. Hum Genet (1979) 1.10
Antihypertensive treatment of the elderly in general practice. J Hum Hypertens (1989) 1.09
Physical map of the malaria vector Anopheles gambiae. Genetics (1996) 1.09
Awareness, treatment, and control of hypertension in the elderly in a general practice experience. Study Group on Hypertension in the Elderly. Clin Cardiol (1989) 1.08
Symptoms, bothersomeness and quality of life in patients with LUTS suggestive of BPH. Eur Urol (2001) 0.99
Left ventricular structure and function in normotensive adolescents with a genetic predisposition to hypertension. Am Heart J (1986) 0.96
Nitric oxide synthases in normal and benign hyperplastic human prostate: immunohistochemistry and molecular biology. J Pathol (1999) 0.94
Heat shock protein-90, IL-6 and IL-10 in bladder cancer. Anticancer Res (2001) 0.91
Leiomyosarcoma of urinary bladder: personal experience in 3 cases over a 10-year period. Arch Ital Urol Androl (1997) 0.88
Hypomelanosis of Ito associated with chromosomal translocation involving Xp11. Am J Med Genet (1991) 0.88
Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation. BJU Int (2004) 0.87
Epidermal growth factor receptor, MUC-1 and MUC-2 in bladder cancer. J Exp Clin Cancer Res (2000) 0.87
Relationship among symptom score, prostate volume, and urinary flow rates in 543 patients with and without benign prostatic hyperplasia. Prostate (1998) 0.87
Lipido-sterolic extract of Serenoa repens (LSESr, Permixon) treatment affects human prostate cancer cell membrane organization. J Cell Physiol (2009) 0.87
Effects of the lipidosterolic extract of Serenoa repens (Permixon) on human prostatic cell lines. Prostate (1996) 0.87
Prevalence and variability of orthostatic hypotension in the elderly. Results of the 'Italian study on blood pressure in the elderly (SPAA)'. The 'Gruppo di Studio Sulla Pressione Arteriosa nell'Anziano'. Eur Heart J (1992) 0.86
Type 1 diabetes mellitus and hyperadrenocorticism in a ferret. Vet Res Commun (2010) 0.85
Human renal cell carcinoma as a hormone-dependent tumor. Cancer Res (1978) 0.85
X-linked mental retardation, microcephaly, and growth delay associated with hereditary bullous dystrophy macular type: report of a second family. Am J Med Genet (1994) 0.85
Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma. Anal Quant Cytol Histol (2001) 0.84
Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens. J Clin Endocrinol Metab (2001) 0.84
Transforming growth factor-beta expression in prostate neoplasia. Anal Quant Cytol Histol (2000) 0.84
Insulin-like growth factor-I and -II in human benign prostatic hyperplasia: relationship with binding proteins 2 and 3 and androgens. Steroids (1998) 0.84
Cancer stem cells in prostate adenocarcinoma: a target for new anticancer strategies. J Cell Physiol (2008) 0.83
Androgen concentrations and their receptors in the periurethral region are higher than those of the subcapsular zone in benign prostatic hyperplasia (BPH). J Androl (1998) 0.83
Effects of a screening program for hypertension in a community. Acta Cardiol (1991) 0.82
Benign prostatic hyperplasia: what about a campaign for prevention? Urol Int (2004) 0.82
Acquired cystic kidney disease: the hormonal hypothesis. Urology (1993) 0.82
Chlamydia trachomatis genitourinary infections: laboratory diagnosis and therapeutic aspects. Evaluation of in vitro and in vivo effectiveness of azithromycin. J Chemother (1994) 0.81
Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasia. Eur Urol (1997) 0.81
A case of human polyomavirus Bk infection in a patient affected by late stage prostate cancer: could viral infection be correlated with cancer progression? Int J Immunopathol Pharmacol (2007) 0.81
Long-term efficacy of screening for hypertension in a community. J Hypertens (1985) 0.80
Steroid receptors and hormone responsiveness of human prostatic carcinoma. Prostate (1982) 0.79
Progestational therapy in human renal carcinoma and steroid receptors. J Steroid Biochem (1977) 0.79
[Role of nitric oxide in the urogenital system: physiology and pathology]. Minerva Urol Nefrol (2000) 0.79
Long-term prognostic impact of repeated measurements over 1 year of pulse pressure and systolic blood pressure in the elderly. J Hum Hypertens (2005) 0.78
Role of blood pressure response to provocative tests in the prediction of hypertension in adolescents. Eur Heart J (1985) 0.78
Transforming growth factor beta 1 and androgen receptors in prostate neoplasia. Anal Quant Cytol Histol (2000) 0.78
Hormonal pattern in prostatic carcinoma following orchidectomy: 5-year follow-up. Br J Urol (1977) 0.78
Human kidney steroid receptors. J Steroid Biochem (1976) 0.78
Hormone-refractory prostate cancer? Anti-androgen withdrawal and intermittent hormone therapy. Scand J Urol Nephrol (1999) 0.78
Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP. Prostate (1995) 0.78
In vitro study of a double infection by herpes simplex virus type 2 and Chlamydia trachomatis. New Microbiol (1996) 0.78
New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma. Int J Clin Pract (2006) 0.78
Prolactin stimulation by intravenous labetalol is mediated inside the central nervous system. Clin Endocrinol (Oxf) (1982) 0.78
Left ventricular diastolic function in normotensive adolescents with different genetic risk of hypertension. Clin Cardiol (1990) 0.78
Plasma testosterone and androstenedione after orchiectomy in prostatic adenocarcinoma. Clin Endocrinol (Oxf) (1973) 0.78
Correspondence re: Ghosh A and Heston WDW. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem 91:528-539, 2004. J Cell Biochem (2004) 0.78
Computed tomography and pattern reversal visual evoked potentials in chronic schizophrenic patients. Acta Psychiatr Scand (1986) 0.77
[Prognosis of shoulder calcifications after irrigation treatment and roentgen findings. A prospective study and literature review]. Praxis (Bern 1994) (1996) 0.77
Renal cancer steroid receptors: biochemical basis for endocrine therapy. Eur Urol (1979) 0.77
Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie's disease and veno-occlusive dysfunction. J Androl (1996) 0.77
Prostate--specific G protein couple receptor genes and STAG1/PMEPA1 in peripheral blood from patients with prostatic cancer. Int J Immunopathol Pharmacol (2006) 0.77
Abnormal patterns of colorectal mucin secretion after urinary diversion of different types: histochemical and lectin binding studies. Hum Pathol (1986) 0.77
Effects of triptorelin, a gonadotropin-releasing hormone agonist, on the human prostatic cell lines PC3 and LNCaP. J Androl (2000) 0.77
Latent myocardial contractile impairment in patients with angina pectoris. Acta Cardiol (1975) 0.76
Mycosis fungoides: disease evolution of the "lion queen" revisited. G Ital Dermatol Venereol (2012) 0.76
Median sternotomy for resection of lung metastases. Ital J Surg Sci (1985) 0.76
Biosynthesis and metabolism of androgenic hormones in cancer of the prostate. Invest Urol (1976) 0.76
Transforming growth factor-beta expression in human testicular neoplasms. Anal Quant Cytol Histol (1998) 0.76
Age-adjusted mortality rate and regional distribution for prostatic carcinoma in Italy between 1969 and 1978. Prostate (1982) 0.76
Immunoreactive EGF in human benign prostatic hyperplasia: relationships with androgen and estrogen receptors. J Steroid Biochem Mol Biol (1992) 0.76
Preliminary observations on the use of propionyl-L-carnitine in combination with sildenafil in patients with erectile dysfunction and diabetes. Curr Med Res Opin (2004) 0.76
Prevalence of symptoms generally attributed to hypertension or its treatment: study on blood pressure in elderly outpatients (SPAA). J Hypertens Suppl (1988) 0.76
Is hyperdiploidy of immature ejaculated germ cells predictive of testis malignancy? A comparative study in healthy normozoospermic, infertile, and testis tumor suffering subjects. Lab Invest (1999) 0.75
Strategy to reformulate waiting lists. Italy's public health system is changing from waiting times to priority. BMJ (1999) 0.75
Penile metastasis from carcinoma of the prostate in a patient with high serum prostate specific antigen levels. Minerva Urol Nefrol (1999) 0.75
Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasia. J Steroid Biochem Mol Biol (1993) 0.75
Effects of two different medical treatments on dihydrotestosterone content and androgen receptors in human benign prostatic hyperplasia. J Steroid Biochem (1988) 0.75
Assessment of ventricular function in arterial hypertension with radionuclide ventriculography. Am J Med (1988) 0.75
[Accuracy of anamnestic data in the definition of the familial history of hypertension]. Cardiologia (1985) 0.75
[M-mode echocardiogram in adolescents genetically predisposed to the development of hypertension]. Cardiologia (1983) 0.75
[Mechanical sutures with the E.E.A. stapler: proposal for the modification of cartridges based on our experience]. Minerva Chir (1988) 0.75
[Low-dose steroids in chronic polyarthritis: a basic therapy?]. Schweiz Rundsch Med Prax (1993) 0.75
[Relations between pressure overload and early signs of cardiac involvement in arterial hypertension]. Cardiologia (1989) 0.75
[M-mode echocardiogram in adolescents genetically predisposed to develop hypertension]. Cardiologia (1983) 0.75
[Evaluation of the diagnostic yield of 2d level indices in arterial hypertension]. Boll Soc Ital Cardiol (1981) 0.75
[Echocardiographic evaluation of the left ventricular morphology and function in adolescents with mild arterial hypertension]. G Ital Cardiol (1985) 0.75
Effects of long-term treatment with prazosin on left ventricular diastolic function in mild to moderate hypertension. Chest (1992) 0.75
[A case of bizarre leiomyoma of the duodenum]. Ann Ital Chir (1985) 0.75
[Index of left ventricular hypertrophy in adolescents genetically predisposed to the development of arterial hypertension]. G Ital Cardiol (1985) 0.75
[Association between arterial pressure and other cardiovascular risk factors in adolescence]. G Ital Cardiol (1985) 0.75
[Variability of arterial pressure in adolescence]. Cardiologia (1983) 0.75
[The role of hypertensive cardiopathy in the genesis of the pathological response to the ergometric test in young hypertensive patients]. Boll Soc Ital Cardiol (1980) 0.75
[Results of the treatment of arterial hypertension: comparison of a specialty center and general practice]. Cardiologia (1983) 0.75
[Usefulness of exertion tests in the evaluation of the effectiveness of antihypertensive therapy]. G Ital Cardiol (1987) 0.75
[Changes in the response to the exercise test, after treatment, in young patients with arterial hypertension]. Boll Soc Ital Cardiol (1980) 0.75
The effect of aging on the P3 component in different auditory paradigms. Rev Electroencephalogr Neurophysiol Clin (1986) 0.75
[Efficacy of screening for arterial hypertension in an adult population]. Cardiologia (1984) 0.75
Accuracy of the anamnestic ascertainment of parental history of hypertension. Am J Epidemiol (1986) 0.75
[Fetal diseases due to hydantoin. Description of a case]. Minerva Pediatr (1980) 0.75
[Evaluation of treatments results in arterial hypertension obtained at 2 levels of intervention: the specialist center and basic medicine]. Boll Soc Ital Cardiol (1980) 0.75
[Hydroxyurea in therapy of inoperable carcinoma of the bladder]. Cancro (1968) 0.75
[Control using omeprazole in a case of upper digestive hemorrhage, induced by erosive uremic hemorrhagic gastritis resistant to conventional therapy]. Medicina (Firenze) (1990) 0.75